Spaceflight Associated Neuro-ocular Syndrome (SANS) is a condition unique to long-duration spaceflight, with an unclear pathogenesis and pathophysiology, and no perfect terrestrial analog. Approximately 69% of long duration astronauts present with the earliest indications of SANS, which is defined as development of one or more of the following new signs in at least one eye during or immediately after spaceflight: 1) optic disc edema (ODE; represented by an increase of ≥ 20 microns in peripapillary total retinal thickness [ΔTRT]); 2) chorioretinal folds; 3) globe flattening; and 4) excessive shift in refractive error (≥ +0.75D). Each of these signs presents potential risk to a crewmember’s vision and mission effectiveness, with ODE posing the highest risk overall. It is not yet known what severity and/or duration of signs represents the “pathological” threshold of SANS, or how this threshold will eventually influence the SANS case definition. Brain anatomical changes also occur during long-duration spaceflight and are being monitored in the astronaut population; however, these changes have not yet been associated with functional decrements or with SANS. An update will be provided on the latest SANS clinical analyses, diagnostic technologies, and program initiatives.
Spaceflight Associated Neuro-ocular Syndrome (SANS): Clinical Update
Human Research Program Investigators Workshop ; 2022 ; Online, US
Miscellaneous
No indication
English